Article

Applied Clinical Trials

The Advanstar Advantage (PDF File)

Find out how you can reach key decision-makers in every area of the pharmaceutical business...

External Link - article-40491.pdf

Newsletter

Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.

Subscribe Now!
Related Videos
Related Content
© Matthieu - © Matthieu - stock.adobe.com
August 12th 2025

Phase III EV-303/KEYNOTE-905 Shows Padcev Plus Keytruda Improves Event-Free and Overall Survival in Muscle-Invasive Bladder Cancer

Andy Studna, Senior Editor
ACT Brief Episode 2: FDA Oversight, Vaccine Funding Cuts, and the Digital Future of Clinical Trials
August 12th 2025

ACT Brief Episode 2: FDA Oversight, Vaccine Funding Cuts, and the Digital Future of Clinical Trials

Andy Studna, Senior Editor
© Matthieu - © Matthieu - stock.adobe.com
August 12th 2025

Zusduri Demonstrates Sustained Efficacy in Phase III ENVISION Trial for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer

Andy Studna, Senior Editor
ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials
August 12th 2025

ACT Brief Episode 1: Placebos, Politics, and the Ethics of Vaccine Trials

Applied Clinical Trials Editorial Staff
© Kaikoro - © Kaikoro - stock.adobe.com
August 12th 2025

AI-Powered Non-Interventional Research Delivers What DCTs Promised

Troy Astorino
Eli Lilly’s Investigational Oral GLP-1 Receptor Agonist Demonstrates Significant Weight Loss
August 12th 2025

Eli Lilly’s Investigational Oral GLP-1 Receptor Agonist Demonstrates Significant Weight Loss

Don Tracy, Associate Editor
© 2025 MJH Life Sciences

All rights reserved.